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Abstracts / Urological Science 26 (2015) S1eS25S6procedures within a post treatment 180-day follow-up period was
analyzed by quartile. A nested case-control study was also performed.
Results: 1,259 patients were eligible for ﬁnal analyses. During 3,980 per-
son-years follow-up, 167 patients had recurrent urolithiasis needed for
surgical intervention. From ﬁrst to fourth quartile of drug exposure,
recurrence rates were 45.64, 47.19, 43.11, and 18.52 per 1,000 person-years.
The adjusted hazard ratio was 0.46 (95% CI ¼ 0.24 to 0.89) for the fourth
quartile (vs. quartile 1). In the nested case-control study, adjusted ORs was
0.23 (95% CI ¼ 0.10 to 0.53) in the fourth quartile (vs. quartile 1).
Conclusion: Use of a-blockers for 180 days or more decrease the risk of
recurrent urolithiasis needed for surgical intervention. In patients at
higher risk of recurent urolithiasis, long term prescription of a-blockers
might help them prevent further surgical intervention.
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Purpose: We evaluated whether the risks of postoperative infection will
be increased in patients with mild pyuria before ureteroscopic lithotripsy
(URSL) in a prospective study.
Materials and Methods: We prospectively enrolled patients receiving
URSL from 2011/5 to 2015/2. The patients with normal urine routine
(sediment WBC 5/HPF) before URSL were assigned as control, and those
with mild pyuria (sediment 5/HPF < WBC 50/HPF ) as experimental
group. Febrile UTI, patients < 18 years, pregnant, and urine sediment WBC
> 50/HPF were excluded. All patients received same protocol of preoper-
ative and postoperative antibiotics. Pre-, intra-operative, and post-opera-
tive urine routine and culture were collected. Peri-operative data were
compared. Post-operative pyuria, febrile episodes, and percentage of
emergency room visits were also compared.
Results: 140 patients were enrolled (experimental: 53, control: 87). Mean
age was 56.6 and 55.5 years, respectively. Patient's BMI, stone laterality,
stone location, and percentage of male patients were similar in both
groups. The mean stone size was 0.84cm vs. 0.76cm (p ¼ 0.243). The
operation duration was 58.8 vs. 49.2 min (p ¼ 0.022). The stone free rate
was 92.5% vs. 90.8%(p ¼ 0.235). Four out of 23 patients in experimental
group had positive pre-operative urine culture, two were E Coli, and two
Gram positive coccus. Two out of 12 patient in control group had positive
pre-operative urine culture, one was E. Coli and one was coagulase nega-
tive staphylococcus group. Two out of 33 patients had positive intra-
operative urine culture in experimental group: one pseudomonas, one
enterococcus species. One out of 46 patients had positive intra-operative
urine culture which was enterococcus species. Both pre-operative culture
and intra-operative culture didn't reach statistical signiﬁcance(p ¼ 0.398,
0.477 respectively). Two patients (3.8%) in the experiment group and none
in control group had post-operative fever but didn't reach statistical sig-
niﬁcance (p ¼ 0.068).
Conclusion: The incidence of postoperative fever increased in patients
with mild pyuria before URSL but didn't reach signiﬁcance compared to
patients with sterile urine.
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Purpose: To assess the safety of outpatient extracorporeal shock wave
lithotripsy (ESWL) in the management of patients with renal and ureteral
stones.
Materials and Methods: Between February 2012 and November 2014, 844
outpatients were treated with Outpatient ESWL at Taipei Veterans General
Hospital. 22 patients visited emergency department (ED) within 48 hours.
Stone size, stone shape (long to short axis ratio), location, total pulse of
shockwaves, stone management and urine analysis data and date before
ESWL, complications and treatment at ER and admission rate was inves-
tigated. Chi-Square and Logistic Regression analyses were used, with
p<0.05 set as the level of signiﬁcance.
Results: Of the 844 initial consecutive patients who underwent ESWL,
1095 times of ESWL was performed totally. There were 22(2%) patients
visited ED within 48 hours after ESWL. Mean Age was 54.3± 12.6 years
old; BMI was 25.9± 3.2; pre-ESWL Cr was 0.89± 2.54 mg/ml; post-
ESWL Cr was 1.04 ± 0.23 mg/ml; stone height/width ratio was
1.80± 0.57. The mean renal stone size was 12.2 ± 5.9 mm;. The mean
ureteral stone size was 6.1 ± 0.2 mm. 8 (8/379 ¼ 2.1%) patients had right
side stone, 14 (14/465 ¼ 3.0%) patients had left side stones. 16 patients
received ESWL for renal stone, 5 patients for ureter stone and 1 patient
for both. The most common complication was ﬂank pain include 16
patients (72.7%). Other complication includes hematuria (5 patients, all
from renal stone), fever (4 patients, all from renal stone), acute urinary
retention and nausea with vomiting (1 patient each). There were 12
patient received EWSL, PCNL, or URSL before. In 22 patient back to ER, 7
patients admitted to ward and 1 patient back to ER twice continuously.
All patients received medical treatment without ESWL or surgical
management.
Conclusion: The 48 hours Emergency Department Visiting rate was 2%.
There was no severe morbidity or mortality case. The tendency risk factors
according to our study include renal stone, large stone height/width ratio,
pre-ESWL stone management. The conclusion showed the outpatient
ESWL is safe for treating renal and ureteral stones.Podium-4
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Purpose: The necessity of bone scans in newly diagnosed prostate cancer
patients is still a matter of debate. We attempt to evaluate the validity of
currently published guidelines by analyzing bone scan results in newly
diagnosed prostate cancer (PCa) patients to determine the optimal staging
strategies.
Materials and Methods: Between January 2011 and July 2014, there were
362 consecutive newly diagnosed PCa patients at Kaohsiung Medical
University Hospital. Bone scans were performed for all patients at initial
staging. Patients positive for bone metastasis were characterized at diag-
nosis in terms of age, prostate-speciﬁc antigen (PSA) level, Gleason score
(GS), and clinical stage. We analyzed the sensitivity and speciﬁcity of the
American Urological Association (AUA) best practice policy, European As-
sociation of Urology guidelines, National Comprehensive Cancer Network
guidelines, and the classiﬁcation and regression tree by Briganti et al. for
diagnostic performance in predicting bone metastasis.
Results: A total 73 of 362 (20.2%) patients were diagnosed with bone
metastasis. Patients positive for metastasis on bone scans had signiﬁcantly
higher PSA levels (943.6 ± 2198.4 ng/mL vs. 56.1± 183.1 ng/mL; p < 0.001)
and higher GSs (8.5± 1.0 vs. 7.0± 1.6; p < 0.001) than those with negative
bone scan results. Pairwise comparisons in receiver operating curve
